BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 15323138)

  • 1. Papillomas and atypical papillomas in breast core needle biopsy specimens: risk of carcinoma in subsequent excision.
    Renshaw AA; Derhagopian RP; Tizol-Blanco DM; Gould EW
    Am J Clin Pathol; 2004 Aug; 122(2):217-21. PubMed ID: 15323138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy.
    Jaffer S; Nagi C; Bleiweiss IJ
    Cancer; 2009 Jul; 115(13):2837-43. PubMed ID: 19402174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needle core biopsy can reliably distinguish between benign and malignant papillary lesions of the breast.
    Carder PJ; Garvican J; Haigh I; Liston JC
    Histopathology; 2005 Mar; 46(3):320-7. PubMed ID: 15720418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma within solitary ductal papilloma of the breast.
    Greif F; Sharon E; Shechtman I; Morgenstern S; Gutman H
    Eur J Surg Oncol; 2010 Apr; 36(4):384-6. PubMed ID: 19646841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome.
    Ahmadiyeh N; Stoleru MA; Raza S; Lester SC; Golshan M
    Ann Surg Oncol; 2009 Aug; 16(8):2264-9. PubMed ID: 19484312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma.
    Page DL; Salhany KE; Jensen RA; Dupont WD
    Cancer; 1996 Jul; 78(2):258-66. PubMed ID: 8674001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of papillary lesions of the breast: can larger core needle biopsy samples identify patients who may avoid surgical excision?
    Shamonki J; Chung A; Huynh KT; Sim MS; Kinnaird M; Giuliano A
    Ann Surg Oncol; 2013 Dec; 20(13):4137-44. PubMed ID: 23943035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S; Loya A; Khalbuss W
    Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast papillomas in the era of percutaneous needle biopsy.
    Sohn V; Keylock J; Arthurs Z; Wilson A; Herbert G; Perry J; Eckert M; Smith D; Groo S; Brown T
    Ann Surg Oncol; 2007 Oct; 14(10):2979-84. PubMed ID: 17549566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of papillary lesions at percutaneous breast biopsy.
    Valdes EK; Tartter PI; Genelus-Dominique E; Guilbaud DA; Rosenbaum-Smith S; Estabrook A
    Ann Surg Oncol; 2006 Apr; 13(4):480-2. PubMed ID: 16474908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma.
    Renshaw AA; Cartagena N; Derhagopian RP; Gould EW
    Am J Clin Pathol; 2002 May; 117(5):797-9. PubMed ID: 12090431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology.
    Noske A; Pahl S; Fallenberg E; Richter-Ehrenstein C; Buckendahl AC; Weichert W; Schneider A; Dietel M; Denkert C
    Hum Pathol; 2010 Apr; 41(4):522-7. PubMed ID: 20004938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.
    Renshaw AA; Derhagopian RP; Martinez P; Gould EW
    Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy.
    Sydnor MK; Wilson JD; Hijaz TA; Massey HD; Shaw de Paredes ES
    Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal biopsy for diagnosis and treatment of intraductal lesions of the breast.
    Matsunaga T; Kawakami Y; Namba K; Fujii M
    Cancer; 2004 Nov; 101(10):2164-9. PubMed ID: 15484220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy.
    Deshaies I; Provencher L; Jacob S; Côté G; Robert J; Desbiens C; Poirier B; Hogue JC; Vachon E; Diorio C
    Breast; 2011 Feb; 20(1):50-5. PubMed ID: 20619647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
    Wagoner MJ; Laronga C; Acs G
    Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.